text:
Category: Links
DiEthylStilbestrol Resources: DES Effects on The Genital Tract
NCBI advances science & health by providing access to biological information
DES Effects on The Genital Tract
NCBI PubMed DiEthylStilbestrol Resources: DES Effects on The Genital Tract.
A clinicopathologic study of vagina and cervix in DES-exposed progeny – 1980
Analysis of the Effect of Estrogen/Androgen Perturbation on Penile Development in Transgenic and Diethylstilbestrol-Treated Mice – 2013
Association of diethylstilbestrol exposure in utero with cryptorchidism, testicular hypoplasia and semen abnormalities – 1979
Birth Defects in the Sons and Daughters of Women who were Exposed in Utero to DES – 1996
Comparative effects of neonatal diethylstilbestrol on external genitalia development in adult males of two mouse strains with differential estrogen sensitivity – 2014
Cryptorchidism and endocrine disrupting chemicals – 2011
Diethylstilbestrol: risks of malignant disease and congenital malformations – 1979
Effect of Estrogen/Androgen Perturbation on Penile Development in DiEthylStilbestrol-treated Mice – 2010
Follow-up study of male and female offspring of DES-exposed mothers – 1977
Follow-up study of male and female offspring of DES-treated mothers a preliminary report – 1975
Hypospadias in Sons of Women exposed to DiEthylStilbestrol in Utero: a cohort study – 2002
Hypospadias in sons of women exposed to diethylstilbestrol in utero – 2005
Hypospadias: a TransGenerational effect of DiEthylStilbestrol? – 2005
Long-Term Effects on the Female Mouse Genital Tract associated with Prenatal Exposure to DiEthylStilbestrol – 1980
Pathological semen and anatomical abnormalities of the genital tract in human male subjects exposed to diethylstilbestrol in utero – 1977
Prenatal diethylstilbestrol exposure and human genital tract abnormalities – 1979
Prenatal diethylstilbestrol induces malformation of the external genitalia of male and female mice and persistent second-generation developmental abnormalities of the external genitalia in two mouse strains – 2014
Prevalence of HypoSpadias in GrandSons of Women exposed to DiEthylStilbestrol during Pregnancy – 2011
Structural anomalies of the cervix and vagina in women enrolled in the Diethylstilbestrol Adenosis (DESAD) Project, – 1984
Structural and functional abnormalities in the sex organs of male offspring of mothers treated with diethylstilbestrol (DES) – 1976
The Effect of DiEthylStilbestrol DES on Male Offspring – 1982
Upper genital tract changes associated with exposure in utero to diethylstilbestrol – 1977
Urogenital Abnormalities in Men exposed to DiEthylStilbestrol in Utero – 2009
Urogenital tract abnormalities in sons of women treated with diethylstilbestrol – 1976
More DES DiEthylStilbestrol Resources
DES studies on cancers and screening.
DES studies on epigenetics and transgenerational effects.
DES studies on fertility and pregnancy.
DES studies on gender identity and psychological health.
DES studies on in-utero exposure to DES and side-effects.
DES studies on the genital tract.
Papers on DES lawsuits.
DES videos and posts tagged DES, the DES-exposed, DES victims.
Author DES DaughterPosted on 16/12/2015 14/08/2016 Categories Blog, Diethylstilbestrol, LinksTags DES, DES-exposed, Estrogen, NCBILeave a comment on DiEthylStilbestrol Resources: DES Effects on The Genital Tract
DiEthylStilbestrol Resources: Epigenetics and Transgenerational Effects
NCBI PubMed DiEthylStilbestrol Resources: Epigenetics and Transgenerational Effects.
Cellular and molecular effects of developmental exposure to diethylstilbestrol: implications for other environmental estrogens – 1995
DES (Diethylstilbestrol) May Suppress Gene Important To Normal Female Reproductive Tract Development – 1998
Developmental exposure to diethylstilbestrol alters uterine gene expression that may be associated with uterine neoplasia later in life – 2008
Diethylstilbestrol (DES)-stimulated hormonal toxicity is mediated by ERα alteration of target gene methylation patterns and epigenetic modifiers (DNMT3A, MBD2, and HDAC2) in the mouse seminal vesicle – 2013
Diethylstilbestrol induces oxidative DNA damage, resulting in apoptosis of spermatogonial stem cells in vitro – 2017
Early Life Adverse Environmental Exposures Increase the Risk of Uterine Fibroid Development: Role of Epigenetic Regulation – 2016
Effects of Neonatal Diethylstilbestrol (DES) Exposure on Morphology and Growth Patterns of Endometrial Epithelial Cells in CD-1 Mice – 1999
Effects of Low-Dose Diethylstilbestrol Exposure on DNA Methylation in Mouse Spermatocytes – 2015
Epigenetic effects of endocrine-disrupting chemicals on female reproduction: an ovarian perspective 2010
Epigenetic Transgenerational Actions of Endocrine Disruptors and Male Fertility – 2010
Environmental factors, epigenetics, and developmental origin of reproductive disorders – 2016
Environmental signaling: from environmental estrogens to endocrine-disrupting chemicals and beyond – 2016
Hsp90 and environmental impacts on epigenetic states: a model for the trans-generational effects of diethylstibesterol on uterine development and cancer – 2005
Hypermethylation of homeobox A10 by in utero diethylstilbestrol exposure: an epigenetic mechanism for altered developmental programming – 2009
In utero exposure to diethylstilbestrol and blood DNA methylation in women ages 40-59 years from the sister study – 2015
In utero exposure to diethylstilbestrol (DES) does not increase genomic instability in normal or neoplastic breast epithelium – 2006
Neonatal exposure to diethylstilbestrol alters expression of DNA methyltransferases and methylation of genomic DNA in the mouse uterus – 2009
Persistent Hypomethylation in the Promoter of Nucleosomal Binding Protein 1 (Nsbp1) Correlates with Overexpression of Nsbp1 in Mouse Uteri Neonatally Exposed to Diethylstilbestrol or Genistein – 2008
Prenatal exposure of mice to diethylstilbestrol disrupts T-cell differentiation by regulating Fas/Fas ligand expression through estrogen receptor element and nuclear factor-κB motifs – 2012
Roles of p63 in the diethylstilbestrol-induced cervicovaginal adenosis – 2003
The orphan nuclear receptor small heterodimer partner mediates male infertility induced by diethylstilbestrol in mice – 2009
The Role of Hox Genes in Female Reproductive Tract Development, Adult Function, and Fertility – 2015
DES Transgenerational Effects
Adverse Effects of the Model environmental Estrogen DES are transmitted to subsequent Generations – 2006
Adverse health effects in children of women exposed in utero to diethylstilbestrol (DES) – 2016
Diethylstilbestrol, teratogenesis, and carcinogenesis: medical/legal implications of its long-term sequelae, including third generation effects – 1990.
Findings in Female Offspring of Women exposed in Utero to DiEthylStilbestrol – 2002
IntraUterine Exposure to DiEthylStilbestrol: long-Term Effects in Humans – 2000
Long-Term Effects of Exposure to #DiEthylStilbestrol – 1988
Medical Conditions among Adult Offspring prenatally exposed to DiEthylStilbestrol – 2013
Pregnant DES Daughters and their Offspring – 2005
Proceedings of the Summit on Environmental Challenges to Reproductive Health and Fertility: Executive Summary, Developmental Programming and Fetal Origins of Adult Disease, The DES Example – 2009
Author DES DaughterPosted on 16/12/2015 08/03/2018 Categories Blog, Diethylstilbestrol, LinksTags DES, DES-exposed, Dr Arthur Herbst, epigenetics, Estrogen, NCBILeave a comment on DiEthylStilbestrol Resources: Epigenetics and Transgenerational Effects
DiEthylStilbestrol Resources: Gender Identity and Psychological Health
NCBI PubMed DiEthylStilbestrol Resources: Gender Identity and Psychological Health.
2016 video Did the DES drug make some children transgender ? – "… and it was one of those moments… when you just go, 'My God, it really is so obvious'… "
2016 video Gender assignment : something in the mind, as opposed to the body – "… until there is a funded a DES transgender link study, there won't be a definitive answer… "
2016 video Real Talk with a DES Son – "… as a male, I was prenatally exposed to medically prescribed hormones… "
2016 video The Controversy about DES and Gender Identity – "… a very good possibility that DES is was caused me to be trans …"
2016 video The possible link between DES and being transgender later in life – "… This is all about education. The more people know, the better off everyone is."
2016 video Thousands of people believe DES is the reason they are transgender – "… we could not talk about this because it was too scary …"
2015 Early exposure of 17α-ethynylestradiol and diethylstilbestrol induces morphological changes and alters ovarian steroidogenic pathway enzyme gene expression in catfish, Clarias gariepinus.
2015 In utero exposure to the oestrogen mimic diethylstilbestrol disrupts gonadal development in a viviparous reptile.
2014 Fetal programming of sexual development and reproductive function.
2014 Our stolen figures: The interface of sexual differentiation, endocrine disruptors, maternal programming, and energy balance.
2013 Prenatal exposure to DES linked to intersexed development in males.
2012 Estrogen receptor-α mediates diethylstilbestrol-induced feminization of the seminal vesicle in male mice.
2012 Specific morphogenetic events in mouse external genitalia sex differentiation are responsive/dependent upon androgens and/or estrogens.
2011 Gender Identity and DES Exposure.
2011 book : Prenatal exposure to progesterone suppresses reproduction in male mice.
2011 Sexual differentiation of the human brain: relation to gender identity, sexual orientation and neuropsychiatric disorders.
2010 Gonadal hormones and sexual differentiation of human behavior : Effects on psychosexual and cognitive development.
2010 Sexual differentiation of the human brain in relation to gender identity and sexual orientation.
2009 Animal model for age- and sex-related genotoxicity of diethylstilbestrol.
2009 Clinical implications of the organizational and activational effects of hormones.
2009 book : The Riddle of Gender – Science, Activism, and Transgender Rights.
2008 DES' other Daughters : Neglected Evidence of Prenatal Gender Development.
2008 Effects of Gestational Diethylstilbestrol Treatment on Male and Female Gonads during Early Embryonic Development.
2008 Environmental endocrine disrupters.
2007 Secondary sex ratio among women exposed to diethylstilbestrol in utero.
2007 Time to pregnancy and secondary sex ratio in men exposed prenatally to diethylstilbestrol.
2006 Atypical Gender Development – A Review.
2006 audio : Dr. Scott Kerlin talks about Diethylstilbestrol DES.
2005 Are EDCs Blurring Issues of Gender?
2005 audio : Dr. Dana Beyer talks about Diethylstilbestrol DES.
2005 Effects of maternal exposure to a low dose of diethylstilbestrol on sexual dimorphic nucleus volume and male reproductive system in rat offspring.
2005 Prenatal DiEthylStilbestrol Exposure in Males and Gender-related Disorders – Results from a 5-year study.
2004 Basic Statistics and Findings on DES Sons Participating in the DES Sons International Network Between 1999 and 2004.
2004 Children's search for gender cues : Cognitive perspectives on gender development.
2004 DES Sons and Gender Dysphoria, Transsexualism, Disorders of Sexual Differentiation.
2004 DES Sons and the Significance of Gender Identity: Statistics of Individuals with Gender-related Issues or Outcomes Among Network Members.
2004 Discordant sexual identity in some genetic males with cloacal exstrophy assigned to female sex at birth.
2004 Disorders of sex differentiation caused by exogenous hormones.
2004 Gender Benders and Endocrine Disruptors around You.
2004 Prevalence of Transsexualism, Transgenderism, Gender Dysphoria, or Intersex among DES-Exposed.
2004 Sexual differentiation of the human brain : relevance for gender identity, transsexualism and sexual orientation.
2004 The Presence of Gender Dysphoria, Transsexualism, and Disorders of Sex Differentiation in Males Prenatally Exposed to Diethylstilbestrol.
2004 Transsexualism : An Unacknowledged Endpoint of Developmental Endocrine Disruption?
2003 Diethylstilbestrol exposure and feminization in males.
2003 Effects on gender identity of prenatal androgens and genital appearance : evidence from girls with congenital adrenal hyperplasia.
2003 Psychosexual characteristics of men and women exposed prenatally to diethylstilbestrol.
2002 Cognitive theories of early gender development.
2002 Environmental endocrine disrupters and disorders of sexual differentiation.
2002 Estrogens and environmental estrogens.
2002 Gender Identity, Sexual Orientation, and Sexual Diversity of DES Sons.
2001 A psycho-endocrinological overview of transsexualism.
2001 Environmental xenoestrogens, antiandrogens and disorders of male sexual differentiation.
1999 Intersexuality and gender identity differentiation.
2011 book : Sexual Differentiation of the Brain.
1999 The avian egg as a test system for endocrine disrupters: effects of diethylstilbestrol and ethynylestradiol on sex organ development.
1999 Transsexualism: a review of etiology, diagnosis and treatment.
1998 Effect of prenatal exposure to diethylstilbestrol on Müllerian duct development in fetal male mice.
1998 Sexual differentiation and environmental endocrine disrupters.
1996 Gender-identity, body-experience, sexuality, and the wish for having children in DES-daughters.
1996 Sexual differentiation of cognitive abilities in women exposed to diethylstilbestrol (DES) prenatally.
1995 A quantitative investigation of gonadal feminization by diethylstilboestrol of genetically male embryos of the quail Coturnix coturnix japonica.
1995 A Sex Difference in the Human Brain and its Relation to Transsexuality.
1995 Diethylstilbestrol revisited : a review of the long-term health effects.
1994 Molecular feminization of mouse seminal vesicle by prenatal exposure to diethylstilbestrol: altered expression of messenger RNA.
1993 Gender-related behavior in women exposed prenatally to diethylstilbestrol.
1991 Gender-related behavior development in females exposed to diethylstilbestrol (DES) in utero: an attempted replication.
1991 Hormonal contributions to sexually dimorphic behavioral development in humans.
1989 Female gene expression in the seminal vesicle of mice after prenatal exposure to diethylstilbestrol.
1988 Prenatal exposure of male mice to diethylstilbestrol alter the expression of the lactotransferrin gene in seminal vesicles.
1985 Effects of estrogen treatment on sexual behavior in male-to-female transsexuals: experimental and clinical observations.
1979 Feminization of the quail by early diethylstilbestrol treatment: histoenzymological investigations on steroid dehydrogenases in the gonads.
1977 Prenatal Exposure to Synthetic Progestins and Estrogens: Effects on Human Development.
1976 Pulmonary embolism in a transsexual man taking diethylstilbestrol.
1972 book : Man and Woman, Boy and Girl – the differentiation and dimorphism of gender identity from conception to maturity.
1959 Male Pseudohermaphrodism – Report of a Case, with Observations on Pathogenesis.
1959 Masculinization of the female infant associated with estrogenic therapy alone during gestation : four cases.
2017 Impact of prenatal exposure to diethylstilbestrol (DES) on psychological outcome: a national survey of DES daughters and unexposed controls.
2016 Endocrine disruptors and psychiatric disorders in children exposed in utero: evidence from a French cohort of 1002 prenatally exposed children and the example of diethylstilbestrol (DES) as a model for PE study.
2016 Environmental signaling: from environmental estrogens to endocrine-disrupting chemicals and beyond.
2016 Methylomic Changes in Individuals with Psychosis and Prenatally Exposed to Diethylstilbestrol.
2015 Association between fetal DES-exposure and psychiatric disorders in adolescence/adulthood : evidence from a French cohort of 1002 prenatally exposed children.
2015 Distilbène et troubles psychiatriques?
2015 Effects of diethylstilbestrol exposure during gestation on both maternal and offspring behavior.
2015 Prenatal exposure to endocrine disruptors and neurodevelopment risk : study of siblings exposed to diethylstilbestrol.
2014 Epigenetics of schizophrenia : a review.
2012 Behavioral and Somatic Disorders in Children Exposed in Utero to Synthetic Hormones: A Testimony-Case Study in a French Family Troop.
2012 Diethylstilbestrol and risk of psychiatric disorders: a critical review and new insights.
2012 Endocrine disrupters: a review of some sources, effects, and mechanisms of actions on behaviour and neuroendocrine systems.
2011 Distilbène, effets psychiatriques – Rapport Hhorages 2011.
2011 Endocrine disruptors and behavioural anomalies.
2011 Endocrine disruptors and behavioural issues.
2011 Prenatal endocrine influences on sexual orientation and on sexually differentiated childhood behavior.
2011 Psychological consequences of DES exposure in utero.
2010 Diethylstilbestrol Exposure in Utero and Depression in Women.
2009 Hypermethylation of Homeobox A10 by in Utero Diethylstilbestrol Exposure: An Epigenetic Mechanism for Altered Developmental Programming.
2007 Effects of xenoestrogens on the differentiation of behaviorally-relevant neural circuits.
2007 Serious psychiatric outcome of subjects prenatally exposed to diethylstilboestrol in the E3N cohort study.
2005 Early exposure to a low dose of bisphenol A affects socio-sexual behavior of juvenile female rats.
2004 Endocrine disrupters as disrupters of brain function: a neurosteroid viewpoint.
2004 Low-dose perinatal diethylstilbestrol exposure affected behaviors and hypothalamic estrogen receptor-alpha-positive cells in the mouse.
2004 Perinatal risk factors for schizophrenia: how specific are they?
2002 Long-term psychiatric and behavioural consequences of prenatal exposure to psychoactive drugs.
2000 A focus group study of DES daughters: implications for health care providers.
2000 Does prenatal exposure to diethylstilbestrol (DES) have psychiatric consequences?
2000 Language lateralization and handedness in women prenatally exposed to diethylstilbestrol (DES).
1999 Prenatal and perinatal risk factors for schizophrenia, affective psychosis, and reactive psychosis of early onset: case-control study.
1999 Prenatal exposure to endocrine disrupting chemicals: effects on behavioral development.
1999 Schizophrenic patients and their first-degree relatives show an excess of mixed-handedness.
1997 Obstetric complications and age at onset in schizophrenia: an international collaborative meta-analysis of individual patient data.
1996 Cerebral lateralization is delayed in children who later develop schizophrenia.
1996 Prenatal exposure to diethylstilbestrol and the mother-daughter relationship.
1996 The effects of diethylstilbestrol (DES) before birth on the development of masculine behavior in juvenile female rhesus monkeys.
1995 Diethylstilbestrol (DES)-Related Endocrine Disturbances in Women : A Story with No End, Yet
1995 Handedness and other laterality indices in women prenatally exposed to DES.
1995 Prenatal estrogens and the development of homosexual orientation.
1994 Androgen and the development of human sex-typical behavior: rough-and-tumble play and sex of preferred playmates in children with congenital adrenal hyperplasia (CAH).
1994 Handedness in women with intrauterine exposure to diethylstilbestrol.
1993 Psychopathology and social functioning in men prenatally exposed to diethylstilbestrol (DES).
1992 Effects of prenatal exposure to diethylstilbestrol (DES) on hemispheric laterality and spatial ability in human males.
1992 Prenatal exposure to diethylstilbestrol (DES): childhood play behavior and adult gender-role behavior in women.
1991 Increased risk of profound weight loss among women exposed to diethylstilbestrol in utero.
1989 The development of gender-related behavior in females following prenatal exposure to diethylstilbestrol (DES).
1988 Physical and psychological problems associated with exposure to diethylstilbestrol (DES).
1987 Depression and diethylstilbestrol exposure in women.
1987 Obstetric complications, neurodevelopmental deviance, and risk of schizophrenia.
1987 Psychopathology in prenatally DES-exposed females: current and lifetime adjustment.
1987 Psychosis and prenatal exposure to diethylstilbestrol.
1986 Prenatal Diethylstilbestrol Exposure : Behavioral Consequences in Humans.
1985 Cerebral lateralization. Biological mechanisms, associations, and pathology.
1985 Estrogens before birth and development of sex-related reproductive traits in the female guinea pig.
1985 Sexual activity level and sexual functioning in women prenatally exposed to diethylstilbestrol.
1985 Sexual orientation after prenatal exposure to exogenous estrogen.
1985 Vulnerability to stress among women with in utero diethylstilbestrol (DES) exposed daughters.
1984 Pre- and postnatal influence of testosterone propionate and diethylstilbestrol on differentiation of the sexually dimorphic nucleus of the preoptic area in male and female rats.
1984 Screening and Management of Diethylstilbestrol Exposed Offspring – Psychological Support.
1983 A randomized double-blind controlled trial of the value of stilboestrol therapy in pregnancy: long-term follow-up of mothers and their offspring.
1980 Observations on the psychological impact of diethylstilbestrol exposure and suggestions on management.
1980 Prenatal 'female hormone' administration and psychosexual development in human males.
1979 Emotional distress in morning-after pill patients.
1978 Abnormal gonadotropin secretory responses to LRH in transsexual women after diethylstilbestrol priming.
1977 Psychological effects of diethylstilbestrol exposure.
1973 Prenatal Exposure to Female Hormones : Effect on Psychosexual Development in Boys.
1959 The Clinical use of Stilboestrol for Suppression of Sexual Behaviour of Chronically Ill Male Psychiatric Patients.
Author DES DaughterPosted on 04/12/2015 29/05/2017 Categories Blog, Diethylstilbestrol, LinksTags DES, DES-exposed, Gender Identity, NCBI, psychiatric disorders, TransGender2 Comments on DiEthylStilbestrol Resources: Gender Identity and Psychological Health
DiEthylStilbestrol Resources: DES Lawsuits
Law Papers and Theories (in Reference to DES Cases)
NCBI PubMed DiEthylStilbestrol Resources: Lawsuits and Various Studies.
2016 The Dutch Act on Collective Settlement of Mass Claims (WCAM) Goes Global Again: A Forum Outside the United States to Resolve Mass Claims Disputes Internationally.
2014 DES daughters in France: experts' points of view on the various genital, uterine and obstetric pathologies, and in utero DES exposure.
2013 Synthetic Hormone Use in Beef and The Us Regulatory Dilemma.
2012 Market Share Liability – Did New York Go Too Far?
2011 Boston Federal Courthouse holds the first DES Breast Cancer court cases on behalf of 53 DES Daughters.
2011 Distilbène®: 20 Years of Legal Battle – DES French lawsuits 1991-2011, DES French court cases history.
2011 Pharmaceutical Product Liability.
2011 Transgenerational Tort Liability for Epigenetic Disease.
2008 Alternative Liability and Deprivation of Remedy: Teaching Old Tort Law New Tricks.
2008 The Bitterest Pill.
2008 The Dutch Class Action (Financial Settlement) Act (WCAM).
2007 Against Genetic Exceptionalism: An Argument in Favor of the Viability of Preconception Genetic Torts.
2007 Compensation for Diethylstilbestrol Injury, an opinion.
2007 Defendant Indeterminacy: New Wine into Old Skins.
2007 (Collective) Settlement effected for damages for victims of diethylstilbestrol (DES).
2005 The Challenge to the Individual Causation Requirement in Mass Products Torts.
2002 Hormones as growth promoters: the precautionary principle or a political risk assessment?
2002 The DES story: long-term consequences of prenatal exposure – Late lessons from early warnings: the precautionary principle 1896–2000.
2001 Consequences of diethylstilbestrol during pregnancy; 50 years later still a significant problem – How long should medical records be kept for the DES-exposed?
2001 Preconception Tort Law in an Era of Assisted Reproduction: Applying a Nexus Test for Duty.
2000 An Examination of the Legal and Ethical Public Policy Consideration Underlying DES Market Share Liability.
1999 Book: Causation and Risk in the Law of Torts – Scientific Evidence and Medicinal Product Liability.
1999 Concert of action by substantial assistance : what ever happened to unconscious aiding and abetting?
1999 Expert witness testimony: a trial judge's perspective.
1998 HIV, Women and Access to Clinical Trials: Tort Liability and Lessons from DES.
1996 Judicially Compelled Disclosure of Researcher's Data: A Judge's View.
1996 Researchers' Reactions to Compelled Disclosure of Scientific Information.
1994 Book: Women and Health Research: Ethical and Legal Issues of Including Women in Clinical Studies (with DES Case Study – DES administration without consent).
1994 The Birth of Preconception Torts in Missouri.
1993 Adapting Due Process to Match Your Tort: In re DES: A Novel Approach to Jurisdiction.
1993 Suspended Judgment – The 1953 Clinical Trial of Diethylstilbestrol During Pregnancy: Could It Have Stopped DES Use?
1991 Market Share Liability in DES Cases: The Unwarranted Erosion of Causation in Fact.
1991 Medicine and the Law; Diethylstilboestrol third-generation injury claims.
1991 Preconception tort liability: recognizing a strict liability cause of action for DES grandchildren.
1991 Preconception Tort Liability – The Duty to Third Generations – Enright v. Eli Lilly & Co.
1991 The Causation Requirement: Guardian of Fairness or Obstacle to Justice – Making Sense of a Decade of DES Litigation.
1991 The Indeterminate Defendant in Products Liability Litigation and a Suggested Approach for Ohio.
1990 Appellate Division Recognizes Preconception Tort Liability in Favor of DES Granddaughter.
1990 Diethylstilbestrol, teratogenesis, and carcinogenesis: medical/legal implications of its long-term sequelae, including third generation effects.
1990 From Res Ipsa Loquitur to Diethylstilbestrol: The Unidentifiable Tortfeasor in California.
1990 Market Share Liability New York Style: Negligence in the Air.
1990 Risk Exposure as Injury: Alleviating the Injustice of Tort Causation Rules.
1988 The Paradox of Statutes of Limitations in Toxic Substances Litigation.
1986 Intra-Industry Joint Liability: Implications for Marketing.
1986 The DES Manufacturer Identification Problem: A Florida Public Policy Approach.
1985 Clinical findings and legal resolution in sexual assault.
1985 Failure to Identify the Defendant in Tort Law: Towards a Legislative Solution.
1984 Fear of Disease and Delayed Manifestation of Injuries: A Solution or a Pandora's Box?
1984 The diethylstilbestrol dilemma. Who should pay?
1983 DES and the Identification Problem.
1983 Book: DES: The Bitter Pill.
1983 Generic Product Risks: The Case Against Comment k and for Strict Tort Liability.
1983 Identifying and Tracing a Population at Risk : The DESAD Project Experience
1983 Proving Causation in Toxic Torts Litigation.
1983 Theories of recovery for DES damage: is tort liability the answer?
1982 Bichler v. Lilly: Applying Concerted Action to the DES Cases.
1982 DES and Emotional Distress: Payton v. Abbott Labs.
1982 Book: Multiple Causation in Tort Law: Reflections on the DES Cases.
1982 Overcoming the indentification burden in DES litigation: the Market Share Liability theory.
1982 Product Liability of the 1980s: Repose Is Not the Destiny of Manufacturers.
1982 Toxic Substances Litigation: DES Cases and Identification of Parties.
1981 California Expands Tort Liability under the Novel Market Share Theory: Sindell v. Abbott Laboratories.
1981 Compensation for Drug Injury, Product liability all dressed up American style.
1981 Book: Daughters at risk: A personal DES history.
1981 Book: DES Daughter: The Joyce Bichler story.
1981 Book: DES: The Complete Story.
1981 Emerging Theories of Proof in Products Liability: Resolving the Problem of Identifying DES Manufacturers.
1981 Lilly, DES and the law.
1981 Market Share Liability: A New Method of Recovery for D.E.S. Litigants.
1981 Book: Market Share Liability: an Answer to the DES Causation Problem.
1981 Market Share Liability adopted to Overcome Defendant Identification Requirement in DES Litigation, Sindell v. Abbott Laboratories.
1981 Market Share Liability for DES (Diethylstilbestrol) Injury: A New High Water Mark in Tort Law: Sindell v. Abbott Laboratories.
1981 Sindell v. Abbott Labs: a Market Share Approach to DES Causation.
1981 Statutes of limitations: the special problem of DES suits.
1981 The Relevancy of Drug Efficacy Evidence in Strict Liability Actions: Needham v. White Laboratories, Inc.
1980 Liability in Mass Immunization Programs.
1980 Limitation of Collateral Estoppel in Products Liability Litigation, Katz v. Eli Lilly & Co.
1980 Manufacturers' Liability Based on a Market Share Theory: Sindell v. Abbott Laboratories.
1980 Payton v. Abbott Laboratories: an analysis of the Massachusetts DES class action suit.
1980 The Liability of Pharmaceutical Manufacturers for Unforeseen Adverse Drug Reactions.
1978 DES and a Proposed Theory of Enterprise Liability.
1978 Products-Liability Class Suits for Injunctive Relief Under Federal Rule 23.
DES Cases
2013 DES Breast Cancer Trial – Settlement reached for the Melnick sisters.
2013 DES Breast Cancer Trial – Jury Selected.
2013 DES Breast Cancer Trial – Jackie White Interview.
2013 DES Breast Cancer Trial – MacCormack Interview.
2013 DES Breast Cancer Trial – McCarthy Interviews.
2012 Mazzei v. Abbott Laboratories & Co.
2007 Galvin v. Eli Lilly & Co.
2007 Kelley v. Eli Lilly & Co.
2006 Clayton v. Eli Lilly & Co.
2005 Baughn v. Eli Lilly & Co.
2005 Bortell v. Eli Lilly & Co.
2005 Dunseth v. Eli Lilly & Co.
2005 Gassmann v. Eli Lilly & Co.
2005 Reeves v. Eli Lilly & Co.
2004 Albers v. Eli Lilly & Co. (2).
2002 Armata v. Abbott Labs. (2).
2001 Armata v. Abbott Laboratories. (1).
1998 Sutowski v. Eli Lilly & Co.
1997 Kurczi v. Eli Lilly & Co.
1997 Matter of New York County DES Actions.
1997 Wetherill v. Eli Lilly & Co. (2).
1997 Wood v. Eli Lilly & Co. (3).
1996 Mevis v. Eli Lilly & Co.
1995 Braune v. Abbott Laboratories.
1995 Fraser v. Eli Lilly & Co.
1995 Jellow v. Abbott Laboratories.
1994 Matter of New York County DES Litigation.
1994 Millar-Mintz v. Abbott Laboratories.
1994 Wind v. Eli Lilly & Co. (2).
1994 Wood v. Eli Lilly & Co.
1993 Ashley v. Boehringer Ingelheim Pharmaceuticals.
1993 Bilello v. Abbott Laboratories.
1993 Burgess v. Eli Lilly & Co. (2).
1993 Moll v. Abbott Laboratories. (2).
1993 Hartnett v. Schering Corp.
1992 Bowe v. Abbott Laboratories, Inc.
1992 Grover v. Eli Lilly & Co.
1992 Hibbs v. Abbott Laboratories.
1992 In Re DES Cases (1971 to 1991).
1992 Matter of DES Market Share Litigation, State of New York.
1992 Moll v. Abbott Lab. (1).
1992 Silveri v. Eli Lilly & Co.
1991 Anderson v. Eli Lilly & Co. (2).
1991 Conley v. Boyle Drug Co. (2).
1991 Enright v. Eli Lilly & Co. (3).
1990 Allen v. Abbott Labs.
1990 Bowen v. Eli Lilly & Co.
1990 Castrignano v. E.R. Squibb & Sons, Inc. (2).
1990 Clark v. Abbott Labs. (2).
1990 Korren v. Eli Lilly & Co.
1990 Krist v. Eli Lilly & Co.
1990 Metauro v. Abbott Labs.
1990 Shields v. Eli Lilly & Co. (3).
1990 Smith v. Eli Lilly & Co. (2).
1990 Singer v. Eli Lilly & Co.
1990 Sorrells v. Eli Lilly & Company.
1989 Besser v. Squibb & Sons.
1989 Clark v. Eli Lilly & Co.
1989 Hymowitz v. Eli Lilly & Co.
1989 Murphy v. Eli Lilly & Co.
1989 Phillips v. Cooper Laboratories.
1988 Brown v. Eli Lilly & Co. memorendum.
1988 Brown v. Superior Court.
1988 Castrignano v. E.R. Squibb & Sons. (1).
1988 Johnson v. Eli Lilly & Co.
1988 Jolly v. Eli Lilly & Co.
1988 Kortenhaus v. Eli Lilly & Co.
1988 Maloney v. American Pharmaceutical Co.
1988 Needham v. White Laboratories, Inc. (2).
1988 Shirkey v. Eli Lilly & Co.
1988 Tidler v. Eli Lilly & Co.
1988 Tigue v. E.R. Squibb & Sons, Inc.
1987 George v. Parke-Davis.
1987 Greene v. Abbott Labs.
1987 Rubel v. Eli Lilly & Co.
1987 Tigue v. Squibb & Sons.
1986 Burnside v. Abbott Laboratories.
1986 Hadden v. Eli Lilly & Co.
1986 Mulcahy v. Eli Lilly & Co.
1985 Anthony v. Abbott Laboratories.
1985 Bogorad v. Eli Lilly & Co.
1985 Cavanaugh v. Abbott Laboratories.
1985 Eli Lilly & Co. v. Home Ins Co. (2).
1985 Errichiello v. Eli Lilly & Co.
1985 Kaufman v. Eli Lilly & Co. (2).
1985 Kensinger v. Abbott Laboratories.
1985 Magallanes v. Superior Court.
1985 McCormack v. Abbott Laboratories.
1985 McMahon v. Eli Lilly & Co.
1985 Murphy v. E.R. Squibb & Sons, Inc.
1985 Pine v. Eli Lilly & Co.
1985 Schaeffer v. Eli Lilly & Co.
1984 Abel v. Eli Lilly & Co. (2).
1984 Collins v. Eli Lilly & Co.
1984 Eli Lilly & Co. v. Home Ins. Co. (1).
1984 Fleishman v. Eli Lilly & Co. (2).
1984 Glater v. Eli Lilly & Co. (2).
1984 Lord v. Parke, Davis & Company.
1984 Martin v. Abbott Laboratories.
1984 Zafft v. Eli Lilly & Co.
1983 Mathis v. Eli Lilly & Co.
1983 McElhaney v. Eli Lilly & Co. (2) memorendum.
1983 McElhaney v. Eli Lilly & Co. (1).
1983 Plummer v. Abbott Laboratories.
1983 Trahan v. E.R. Squibb & Sons, Inc.
1983 Wetherill v. University of Chicago : DES administration without consent.
1983 Yustick v. Eli Lilly & Co.
1982 Bichler v. Eli Lilly & Co. (2).
1982 Dawson v. Eli Lilly & Co.
1982 Helmrich v. Eli Lilly & Co.
1982 Miles Laboratories, Inc. v. Superior Court.
1982 Morton v. Abbott Laboratories.
1982 O'Brien v. Eli Lilly & Co.
1982 Payton v. Abbott Labs. (2) memorendum.
1982 Pipon v. Burroughs-Wellcome Co.
1982 Renfroe v. Eli Lilly & Co.
1981 Diamond v. E.R. Squibb & Sons, Inc. (2).
1981 Mizell v. Eli Lilly & Co.
1981 Namm v. Charles E. Frosst & Co.
1981 Payton v. Abbott Labs. (1).
1981 Ryan v. Eli Lilly & Co.
1981 Tate v. Eli Lilly & Co.
1980 Ferrigno v. Eli Lilly & Co.
1980 Sindell v. Abbott Laboratories.
1979 Abel v. Eli Lilly & Company. (1).
1979 Lyons v. Premo Pharmaceutical Labs, Inc.
1979 Morrissy v. Eli Lilly & Co.
1978 Gray v. United States.
1978 McCreery v. Eli Lilly & Co.
1978 Mink v. University of Chicago : DES administration without consent.
1977 Bichler v. Willing : first DES case.
For different topics (than law-related), go first to Diethylstilbestrol DES Studies.
Author DES DaughterPosted on 11/10/2014 22/12/2016 Categories Blog, Diethylstilbestrol, Lawsuits, LinksTags DES, DES-exposed4 Comments on DiEthylStilbestrol Resources: DES Lawsuits
DiEthylStilbestrol Resources: Fertility and Pregnancy
DES and Fertility
2016 Low-dose and combined effects of oral exposure to bisphenol A and diethylstilbestrol on the male reproductive system in adult Sprague-Dawley rats.
2015 EDC-2: The Endocrine Society's Second Scientific Statement on Endocrine-Disrupting Chemicals.
2012 Fertility of Tall Girls Treated with High-Dose Estrogen, a Dose-Response Relationship.
2011 Fertility and ovarian function in high-dose estrogen-treated tall women.
2009 Endocrine-Disrupting Chemicals: an Endocrine Society Scientific Statement.
2007 Reproductive performance of women with müllerian anomalies.
2006 Menstrual and reproductive characteristics of women whose mothers were exposed in utero to diethylstilbestrol (DES).
2005 Reproductive outcomes in men with prenatal exposure to diethylstilbestrol.
2004 Oestrogen treatment to reduce the adult height of tall girls: long-term effects on fertility.
2001 Infertility among women exposed prenatally to diethylstilbestrol.
1999 Effect of in-utero diethylstilboestrol exposure on human oocyte quality and fertilization in a programme of in-vitro fertilization.
1998 Female fertility prognosis and diethylstilbestrol. Personal data and review of the literature.
1995 Fertility in Men Exposed Prenatally to Diethylstilbestrol.
1993 Drug surveillance and reproduction: the bad example of distilbene.
1988 Infertility among daughters either exposed or not exposed to diethylstilbestrol.
1986 An update on DES in the field of reproduction.
1986 Intractable primary infertility in women exposed to diethylstilbestrol in utero.
1986 Primary infertility in women exposed to diethylstilboestrol in utero.
1986 Upper genital tract changes and infertility in diethylstilbestrol-exposed women.
1983 Infertility in women exposed to diethylstilbestrol in utero.
1981 Possible relationship between in utero diethylstilbestrol exposure and male fertility.
1980 Fertility and outcome of pregnancy in women exposed in utero to diethylstilbestrol.
1980 Impaired reproductive performance in DES-exposed women.
1979 Association of diethylstilbestrol exposure in utero with cryptorchidism, testicular hypoplasia and semen abnormalities.
1978 DES Effect on Males.
1977 Pathological semen and anatomical abnormalities of the genital tract in human male subjects exposed to diethylstilbestrol in utero.
1976 Structural and functional abnormalities in the sex organs of male offspring of mothers treated with diethylstilbestrol.
DES and Pregnancy
2013 Exposure to Diethylstilbestrol during Sensitive Life Stages: A legacy of heritable health effects.
2011 Adverse health outcomes in women exposed in utero to diethylstilbestrol.
2011 Surgical approach to and reproductive outcome after surgical correction of a T-shaped uterus.
2011 Term delivery rate after hysteroscopic metroplasty in patients with recurrent spontaneous abortion and T-shaped, arcuate and septate uterus.
2009 Effects of exposure period and dose of diethylstilbestrol on pregnancy in rats.
2007 Preeclampsia risk in women exposed in utero to diethylstilbestrol.
2005 Early prophylactic cervical cerclage for hypoplastic cervix following exposure to DES in utero.
2003 Oestrogen supplementation, mainly diethylstilbestrol, for preventing miscarriages and other adverse pregnancy outcomes.
2001 Effects of Mullerian anomalies on in vitro fertilization outcome.
2000 Continued follow-up of pregnancy outcomes in diethylstilbestrol-exposed offspring.
1999 Effect of diethylstilbestrol on reproductive function.
1997 Outcome of IVF in DES-exposed daughters: experience in the 90s.
1996 Beneficial effect of hysteroscopic metroplasty on the reproductive outcome in a T-shaped uterus.
1996 Endometrial pattern in diethylstilboestrol-exposed women undergoing in-vitro fertilization may be the most significant predictor of pregnancy outcome.
1996 Hysteroscopic metroplasty in diethylbestrol-exposed and hypoplastic uterus: a report on 24 cases.
1996 Transvaginal ultrasound studies of vascular and morphological changes in uteri exposed to diethylstilbestrol in utero.
1995 Effect of diethylstilbestrol or zeranol on fetal development, gestation duration, and number of offspring in NMRI mice.
1995 Pregnancy after transposition and repositioning of the ovaries in a patient with clear-cell adenocarcinoma.
1991 Cervical cerclage in early pregnancy.
1991 Refocusing on the gynecological and obstetrical consequences of intrauterine exposure to diethylstilbestrol (DES).
1990 Are implantation and pregnancy outcome impaired in diethylstilbestrol-exposed women after in vitro fertilization and embryo transfer?
1989 Ultrasound surveillance of the cervix during pregnancy in diethylstilbestrol-exposed offspring.
1988 Adverse outcomes of pregnancy in women exposed to diethylstilbestrol in utero.
1988 Outcome of pregnancy in patients exposed in utero to diethylstilbestrol. Survey by the National College of French Gynecologists and Obstetricians.
1988 Pregnancy after gamete intrafallopian transfer in a woman with primary infertility and in utero exposure to diethylstilbestrol. A case report.
1987 Management of the diethylstilbestrol-exposed pregnant patient: a prospective study.
1984 Experience with diethylstilbestrol-exposed infertile women in a program of in vitro fertilization.
1983 Complications of pregnancy in mice exposed prenatally to DES.
1983 Exposure to diethylstilbestrol during intrauterine life. Signs that should suggest this. Therapeutic implications.
1982 Pregnancy Outcome in 98 Women Exposed to Diethylstilbestrol In Utero, Their Mothers, and Unexposed Siblings.
1981 Pregnancy outcome in women exposed to diethylstilbestrol in utero.
1981 Reproductive and gynecologic surgical experience in diethylstilbestrol-exposed daughters.
1981 Reproductive performance of DES-exposed female progeny.
1981 Structure and function of the fallopian tubes following exposure to diethylstilbestrol (DES) during gestation.
1980 A comparison of pregnancy experience in DES-exposed and DES-unexposed daughters.
1980 Placental changes due to administration of diethylstilbestrol (DES).
1980 Reproductive Outcome of Women exposed to Diethylstilbestrol In Utero.
1980 Reproductive problems in the DES-exposed female.
1971 Diethylstilbestrol Contraindicated in Pregnancy Selected Item from the FDA Drug Bulletin—November 1971.
1954 The importance of controls in a clinical experiment; stilbestrol therapy in pregnancy.
1953 Effect of stilbestrol on pregnancy compared to the effect of a placebo.
1952 Diethylstilbestrol tested on pregnant women without their consent, ethical issues of including those women in clinical studies.
1948 Diethylstilbestrol in the prevention and treatment of complications of pregnancy.
Author DES DaughterPosted on 04/04/2014 20/05/2016 Categories Blog, Diethylstilbestrol, LinksTags DES, DES-exposed, Dr Arthur Herbst, FDA, Fertility, NCBI, Pregnancy2 Comments on DiEthylStilbestrol Resources: Fertility and Pregnancy
DiEthylStilbestrol Resources: Gestational DES-Exposure and Side-Effects
In-Utero Exposure to DES
NCBI PubMed DiEthylStilbestrol Resources: Fetal DES-Exposure and Side-Effects.
2017 Current perspective of diethylstilbestrol (DES) exposure in mothers and offspring.
2014 Diethylstilbestrol story.
2014 Outcome and follow-up of diethylstilbestrol (DES) exposed individuals
2011 NIH Research on the Health Effects of Diethylstilbestrol
2005 The History of DES, Lessons to be learned.
2004 Diethylstilbestrol exposure.
2003 CDC DES Update, for you, your family, and your health care provider.
2002 DES exposure and the aging woman: mothers and daughters.
2001 Consequences of DiEthylStilbestrol during Pregnancy ; 50 Years later still a Significant Problem.
1988 Long-Term Effects of Exposure to DiEthylStilbestrol.
1987 The effects in the human of DiEthylStilbestrol (DES) use during pregnancy.
1980 DES Diethylstilbestrol, National Women's Health Network, Resource Guide 6.
DES Side Effects
– Bones
Alterations in Estrogen Levels during Development affects the Skeleton – 1996
Alterations of maternal Estrogen Levels during Gestation affect the Skeleton of Female Offspring – 1995
Effect of in utero exposure to diethylstilbestrol on lumbar and femoral bone, articular cartilage, and the intervertebral disc in male and female adult mice progeny with and without swimming exercise – 2012
– Endometriosis
Early-life factors and endometriosis risk – 2015
Effects of Prenatal Environmental Exposures on the Development of Endometriosis in Female Offspring – 2016
In utero exposures and the incidence of endometriosis – 2004
– Menarche
Age at menarche among diethylstilbestrol granddaughters – 1995
Menarche, menopause, years of menstruation, and the incidence of osteoporosis: the influence of prenatal exposure to diethylstilbestrol – 2014.
Preterm Birth, fetal Growth, Age at Menarche among Women exposed prenatally to DiEthylStilbestrol – 2011
– Menopause
Age at natural Menopause in Women exposed to DiEthylStilbestrol in Utero – 2006
Effects on the Menstrual Cycle of in Utero Exposure to DiEthylStilbestrol – 1994
The association between in utero cigarette smoke exposure and age at menopause – 2008.
Prenatal diethylstilbestrol exposure and reproductive hormones in premenopausal women – 2015
– Obesity
Developmental Exposure to Endocrine Disruptors and the Obesity Epidemic – 2007
Developmental exposure to estrogenic compounds and obesity – 2005
Endocrine Disruptors and Obesity – 2017
Environmental Estrogens and Obesity: the Developmental Exposed DES Animal Model – 2009
Perinatal exposure to environmental estrogens and the development of obesity – 2007
Prenatal diethylstilbestrol exposure and risk of obesity in adult women – 2015
– Various Studies
A focus group study of DES daughters: implications for health care providers – 2000
Adverse Health Outcomes in Women exposed in Utero to DiEthylStilbestrol – 2011
Antenatal exposure to DES: lessons learned…future concerns – 2007
Autoimmune Disease Incidence among Women prenatally exposed to Diethylstilbestrol – 2010.
Birth defects in the sons and daughters of women who were exposed in utero to diethylstilbestrol (DES) – 2010
Correlation of Mother's Recall of DiEthylStilbestrol History with obstetrical Records – 1990
Cytology of 575 young women with prenatal exposure to diethylstilbestrol – 1976
Design and preliminary observations of National Cooperative Diethylstilbestrol Adenosis (DESAD) Project, – 1978
Developmental exposure to diethylstilbestrol (DES) alters uterine response to estrogens in prepubescent mice: low versus high dose effects – 2004
DiEthylStilbestrol and other Sex Hormones during Pregnancy – 1981
Diethylstilbestrol in pregnancy: an update – 1982
Differential Effects of Bisphenol A and Diethylstilbestrol on Human, Rat and Mouse Fetal Leydig Cell Function – 2012
Effects of diethylstilbestrol exposure during gestation on both maternal and offspring behavior – 2015
Effects of prenatal exposure to diethylstilbestrol (DES) on hemispheric laterality and spatial ability in human males – 1992
Endocrine disrupting chemicals and disease susceptibility – 2011
Gestational exposure to diethylstilbestrol alters cardiac structure/function, protein expression and DNA methylation in adult male mice progeny – 2013
Health risks and effects of prenatal exposure to diethylstilbestrol – 1983
Human papillomavirus associated with vaginal intraepithelial neoplasia in women exposed to diethylstilbestrol in utero – 1987
Increased incidence of cervical and vaginal dysplasia in 3,980 diethylstilbestrol-exposed young women. Experience of the National Collaborative Diethylstilbestrol Adenosis Project – 1984
In utero exposure to DES. Evaluation and followup of 199 women – 1978
Mortality in Women given DiEthylStilbestrol during Pregnancy – 2006
Not just a cervical ectropion. Three case reports of diethylstilbestrol (DES) exposed women presenting with vaginal discharge and cervical ectropion – 1999
Physiological effects and mechanisms of action of endocrine disrupting chemicals that alter estrogen signaling – 2010
Prenatal diethylstilbestrol exposure and performance on college entrance examinations – 1992
Prenatal Diethylstilbestrol Exposure and Risk of Uterine Leiomyomata in the Nurses' Health Study II – 2013
Secondary sex ratio among women exposed to diethylstilbestrol in utero – 2007.
The effects of diethylstilbestrol administration on rat kidney. Ultrastructural study – 2013
The National DES Education Program: effectiveness of the California Health Provider Intervention – 2002
The Role of the Estrogen Receptor in DiEthylStilbestrol Toxicity – 1985
Time to pregnancy and secondary sex ratio in men exposed prenatally to diethylstilbestrol – 2007.
Vaginal and cervical squamous cell dysplasia in women exposed to diethylstilbestrol in utero – 1978
Author DES DaughterPosted on 31/12/2013 25/05/2017 Categories Blog, Diethylstilbestrol, LinksTags DES, DES-exposed, Dr Arthur Herbst, Estrogen, NCBI4 Comments on DiEthylStilbestrol Resources: Gestational DES-Exposure and Side-Effects
DiEthylStilbestrol Resources: Cancer, Breast Cancer, CCAC, Vaginal Cancer, Screening
NCBI PubMed DiEthylStilbestrol Resources: Cancer, Breast Cancer, CCAC, Vaginal Cancer, Screening.
Aneuploidy Induction and Cell Transformation by Diethylstilbestrol: A Possible Chromosomal Mechanism in Carcinogenesis – 1983
Animal models of prenatal exposure to diethylstilboestrol – 1989
Cancer risk in DES daughters – 2010
Cancer risk in diethylstilbestrol-exposed offspring – 1976
Cancer Risk in Men exposed in Utero to DiEthylStilbestrol – 2001
Cancer Risk in Women exposed to DiEthylStilbestrol in Utero – 1998
Cancer Risk in Women prenatally exposed to DiEthylStilbestrol – 2007
Childhood cancer: overview of incidence trends and environmental carcinogens – 1995
Critical windows of exposure for children's health: cancer in human epidemiological studies and neoplasms in experimental animal models – 2000
Diethylstilbestrol Genetics, Teratogenesis, and Tumor Spectrum in Humans – 1985
Diethylstilboestrol: Pharmacology, Toxicology and Carcinogenicity in Experimental Animals – 1992
Endocrine Disruptors in Female Reproductive Tract Development and Carcinogenesis – 2009
Epidemiological studies of the effects of diethylstilboestrol – 1989
Increased tumors but uncompromised fertility in the female descendants of mice exposed developmentally to diethylstilbestrol – 1998
Introduction and overview. Perinatal carcinogenesis: growing a node for epidemiology, risk management, and animal studies – 2004
Lessons learned from Perinatal Exposure to DiEthylStilbestrol – 2004
Multi-generational Carcinogenesis from DiEthylStilbestrol investigated by Blastocyst Transfers in Mice – 1995
Occurrence of tumours in the descendants of CBA male mice prenatally treated with diethylstilbestrol – 1992
Offspring of women exposed in utero to diethylstilbestrol (DES): a preliminary report of benign and malignant pathology in the third generation – 2008
Proliferative lesions and reproductive tract tumors in male descendants of mice exposed developmentally to diethylstilbestrol – 2000
Risk of benign gynecologic tumors in relation to prenatal diethylstilbestrol exposure – 2005
– Breast Cancer
2015 Bisphenol-A and diethylstilbestrol exposure induces the expression of breast cancer associated long noncoding RNA HOTAIR in vitro and in vivo.
2014 Maternal exposure to diethylstilbestrol during pregnancy and increased breast cancer risk in daughters.
2013 Does cancer start in the womb? Altered mammary gland development and predisposition to breast cancer due to in utero exposure to endocrine disruptors.
2013 Exposure to Synthetic Estrogens at different Times during the Life and their Side Effects on Breast Cancer Risk.
2013 Prenatal DES Exposure in Relation to Breast Size
2010 In Utero Exposure to Diethylstilbestrol (DES) or Bisphenol-A (BPA) Increases EZH2 Expression in the Mammary Gland: An Epigenetic Mechanism Linking Endocrine Disruptors to Breast Cancer
2006 Birth weight and breast cancer risk.
2006 Prenatal DiEthylStilbestrol Exposure and Risk of Breast Cancer.
2005 Breast cancer incidence in women prenatally exposed to maternal cigarette smoke.
2005 Management of breast cancer in patients prenatally exposed to diethylstilbestrol: are we prepared?.
2002 Risk of breast cancer in women exposed to diethylstilbestrol in utero: prelimiinary results (United States).
2001 Long-Term Cancer Risk in Women given DiEthylStilbestrol (DES) during Pregnancy.
1993 Breast cancer in mothers prescribed diethylstilbestrol in pregnancy. Further follow-up.
1978 A Twenty-Five-Year Follow-Up Study of Women exposed to DiEthylStilbestrol during Pregnancy.
– Clear Cell AdenoCarcinoma and Vaginal Cancer
A case of vaginal adenocarcinoma after uterine exposure to diethylstilbestrol – 1985
Age-incidence and risk of diethylstilbestrol-related clear cell adenocarcinoma of the vagina and cervix – 1977
Atypical vaginal adenosis and cervical ectropion. Association with clear cell adenocarcinoma in diethylstilbestrol-exposed offspring – 1984
Adenocarcinoma of the Vagina — Association of Maternal Stilbestrol Therapy with Tumor Appearance in Young Women – 1971
Clear Cell AdenoCarcinoma and the current Status of DES-exposed Females – 1981
Clear Cell Adenocarcinoma of the Ovary Associated With In Utero Diethylstilbestrol Exposure: Case Report and Clinical Overview – 2009.
Clear cell adenocarcinoma of the vagina and cervix. An update of the central Netherlands registry showing twin age incidence peaks – 1997.
Clear cell adenocarcinoma of the vagina and cervix: incidence, undetected disease, and diethylstilbestrol – 1988
Clear cell adenocarcinoma of the vagina and cervix secondary to intrauterine diethylstilbestrol exposure – 1990
Clear cell carcinoma of the cervix: a multi-institutional review in the post-DES era – 2008
Colposcopic evaluation of DES-exposed progeny at two large medical centers: the squamous neoplasia problem – 1978
Development of cervical and vaginal squamous cell neoplasia as a late consequence of in utero exposure to diethylstilbestrol – 2008
Diethylstilbestrol (DES)-induced clear cell adenocarcinoma of the vagina metastasizing to the brain – 2007
Dysplasia and cytologic findings in 4,589 young women enrolled in diethylstilbestrol-adenosis (DESAD) project – 1981
Epidemiologic aspects and factors related to survival in 384 Registry cases of clear cell adenocarcinoma of the vagina and cervix – 1979
Epidemiology of vaginal adenosis and adenocarcinoma associated with exposure to stilbestrol in utero – 1977
Follow-up of Patients with Clear-Cell Adenocarcinoma of the Vagina and Cervix – 2018.
Genital clear cell adenocarcinoma – 1983
Incidence of squamous neoplasia of the cervix and vagina in DES-exposed daughters – 2000
Incidence of squamous neoplasia of the cervix and vagina in women exposed prenatally to diethylstilbestrol (United States) – 2001
Ovarian Carcinoma in an Adolescent with TransGenerational Exposure to DiEthylStilbestrol – 2003
Prenatal diethylstilbestrol exposure and high-grade squamous cell neoplasia of the lower genital tract – 2016
Primary Vaginal Mucinous Adenocarcinoma of Intestinal Type, Associated With Intestinal Metaplasia of Skene Ducts in a Diethylstilbestrol-Exposed Woman – 2015
Rates and risks of diethylstilbestrol-related clear-cell adenocarcinoma of the vagina and cervix. An update – 1987
Risk of cervical intra-epithelial neoplasia and invasive cancer of the cervix in DES daughters – 2016
Squamous cell dysplasia and carcinoma in situ of the cervix and vagina after prenatal exposure to diethylstilbestrol – 1978
Squamous cell carcinoma in situ of the vagina and cervix after intrauterine DES exposure – 1978
The Development of Cervical and Vaginal Adenosis as a Result of Diethylstilbestrol Exposure In Utero – 2012
Vaginal Adenosis and AdenoCarcinoma in Mice exposed PreNatally or NeoNatally to DiEthylStilbestrol – 1982
Vaginal adenosis and diethylstilboestrol – 1984
Vaginal and Cervical Abnormalities, including CCA, related to PreNatal Exposure to Stilbestrol – 1974
Vaginal and cervical cancers and other abnormalities associated with exposure in utero to diethylstilbestrol and related synthetic hormones – 1977
Vaginal and cervical cancer due to diethylstilbestrol (DES); end epidemic – 2009.
Very late recurrence of Diethylstilbestrol – related clear cell carcinoma of the cervix: case report – 2015
– Screening
Breast Cancer Screening in Women exposed in Utero to DiEthylStilbestrol – 2009
Cervical and vaginal cancer detection at a regional diethylstilbestrol (DES) screening clinic – 1988
Cervical intraepithelial neoplasia associated with exposure to diethylstilbestrol in utero: a clinical and pathologic study – 1981
Cervical screening and general physical examination behaviors of women exposed in utero to diethylstilbestrol – 2008
Colposcopic findings and intraepithelial neoplasia in diethylstilbestrol-exposed offspring. The Dutch experience – 1990
Development of DES-associated clear-cell carcinoma: the importance of regular screening – 1979
Diethylstilbestrol (DES) update: recommendations for the identification and management of DES-exposed individuals – 2003
Factors associated with a lack of pap smear utilisation in women exposed in utero to diethylstilbestrol – 2015
Identification and management of DES-exposed women – 1988
Magnetic resonance imaging of Müllerian duct anomalies in children – 2016
Mammography Screening Behaviors of Women exposed prenatally to DiEthylStilbestrol – 2012
Six years' experience with screening of a diethylstilbestrol-exposed population – 1979
The management of DES-exposed women: one physician's approach – 1976
Value of screening procedures for the detection of vaginal adenosis – 1976
Author DES DaughterPosted on 08/09/2013 06/05/2018 Categories Blog, Diethylstilbestrol, LinksTags Breast cancer, Cancer, CCA, Clear Cell Adenocarcinoma, DES, DES-exposed, Dr Arthur Herbst, Estrogen, NCBI, Screening, squamous neoplasia, Vaginal Adenosis10 Comments on DiEthylStilbestrol Resources: Cancer, Breast Cancer, CCAC, Vaginal Cancer, Screening
DES DiEthylStilbestrol Resources (6)
Want to know more about the pregnancy drug DiEthylStilbestrol?
Five Scary and Shocking Facts about Diethylstilbestrol
Drug companies ignored DES studies results, the FDA did NOT ban the DES drugs, it continued to be used and many new doctors don't even know about Diethylstilbestrol.
Online Global DES Health History Survey
Calling all DES Mothers, Daughters and Sons!
Did you take part in the new 2012 Diethylstilbestrol health history survey created by DES Action USA and open to all DES-exposed individuals worldwide.
DES Daughters
What is a DES Daughter? Who are they?
Women born between 1938 and 1978, exposed to the anti miscarriage drug Diethylstilbestrol before birth (in the womb) are defined as DES Daughters.
DES Sons
What is a DES Son? Who are they?
Men born between 1938 and 1978, exposed to the anti miscarriage drug Diethylstilbestrol before birth (in the womb) are defined as DES Sons.
1000 Thanks to our 1000 Facebook Fans !
June 21th 2012 marks a Milestone in our efforts to raise awareness of the DES drug scandal and tragedy with 1000 Fans on Facebook.
Author DES DaughterPosted on 25/06/2012 01/02/2016 Categories Blog, Diethylstilbestrol, LinksTags Cancer, DES, Facebook, FDA, Food and Drug Administration, Miscarriage2 Comments on DES DiEthylStilbestrol Resources (6)
Thousands of women could be at risk from silent Thalidomide
Since Sunday 22nd January 2012, there has been an unprecedented flurry of media attention on DES related health issues in the United Kingdom. This comes after two journalists – Sarah Morrison and Jaymi McCann – thoroughly investigated DES issues in the UK and published an exclusive DES report in the Independent on Sunday: "Thousands of women could be at risk from silent Thalidomide". Very quickly ripple effects started and the story spread not only throughout the country but as far as the U.S. and Australia. Many newspapers and websites caught up on the story thus increasing DES awareness locally and nationally and forcing UK health websites to update their DES information.
"Silent Thalidomide" the Secret Killer – Ten of thousands of British women in pregnancy drug scare – Exclusive Report
TOMORROW'S FRONT PAGE: Defiant Huhne accuses No 10 of dirty tricks pic.twitter.com/YVlj0QO6
— IndependentOnSunday (@IndyOnSunday) January 21, 2012
Independent on Sunday – Jan 22, 2012 : "Thousands of women could be at risk from silent Thalidomide"
Daily Mail – Jan 22, 2012 : 'Silent Thalidomide': Thousands of mothers and their daughters at risk of cancer from anti-miscarriage drugs they took decades ago
Lifestyle AOl – Jan 22, 2012 : "Anti-miscarriage drug could cause cancer in daughters of women who took it decades ago"
Yorkshire Post – Jan 23, 2012 : "Call for compensation over pregnancy drug "
Press Association ( UKPA) – Jan 22, 2012 : "Lawyer hunts for UK 'DES daughters'"
Once the story was published by the UK Press Association it started to spread all over the country, here are a few websites where it was re-published:
London Evening Standard – Jan 22, 2012 : "Lawyer hunts for UK 'DES daughters'"
Yahoo News – Jan 22, 2012 : "Lawyer hunts for UK 'DES daughters"
Topix, Local News Bristol – Jan 22, 2012 : "Lawyer hunts for UK 'DES daughters"
The Bucks Herald – Jan 22, 2012 : "Lawyer hunts for UK 'DES daughters"
Fenland Citizen – Jan 22, 2012 : "Lawyer hunts for UK 'DES daughters"
Crawley and Horley Observer – Jan 22, 2012 : "Lawyer hunts for UK 'DES daughters"
Pendle Today – Jan 22, 2012 : "Lawyer hunts for UK 'DES daughters"
Harvill Echo – Jan 22, 2012 : "Lawyer hunts for UK 'DES daughters"
Boston Standard – Jan 22, 2012 : "Lawyer hunts for UK 'DES daughters"
Buckingham Today – Jan 22, 2012 : "Lawyer hunts for UK 'DES daughters"
Leigh Reporter – Jan 22, 2012: "Lawyer hunts for UK 'DES daughters"
Halifax Courier, the Voice of Calderdale – Jan 22, 2012: "Lawyer hunts for UK 'DES daughters"
Selby Times – Jan 22, 2012 : "Lawyer hunts for UK 'DES daughters"
Peterborough Today – Jan 22, 2012 : "Lawyer hunts for UK 'DES daughters"
Newmarket Journal – Jan 22, 2012 : "Lawyer hunts for UK 'DES daughters"
Scaborough Evening News – Jan 22, 2012 : "Lawyer hunts for UK 'DES daughters"
Hastings & St Leonards Observer – Jan 22, 2012 : "Lawyer hunts for UK 'DES daughters"
Hemel Today – Jan 27, 2012 : "Lawyer hunts for UK 'DES daughters"
Isle of Man Examiner – Jan 22, 2012 : "Lawyer hunts for UK 'DES daughters"
Sussex Express – Jan 22, 2012 : "Lawyer hunts for UK 'DES daughters"
IC Newcastle – Jan 22, 2012 : "Lawyer hunts for UK 'DES daughters"
Diss Express – Jan 22, 2012 : "Lawyer hunts for UK 'DES daughters"
News Post Leader – Jan 22, 2012 : "Lawyer hunts for UK 'DES daughters"
Guardian – Jan 22, 2012 : "Lawyer hunts for UK 'DES daughters"
Fleetwood Weekly News – Jan 22, 2012 : "Lawyer hunts for UK 'DES daughters"
Suffolk Free Press – Jan 22, 2012 : "Lawyer hunts for UK 'DES daughters"
Thame Gazette – Jan 22, 2012 : "Lawyer hunts for UK 'DES daughters"
Pocklington Post – Jan 22, 2012 : "Lawyer hunts for UK 'DES daughters"
………………………. The list continues endlessly to cover 16 Google Search Pages. Enter "Lawyer hunts for UK 'DES daughters" in your Google Search Box for the full list. Jaymi McCann's report in the Independent on Sunday truly created ripples, waves, or should I say rather a tsunami in the UK Press.
I am thrilled that the work my husband and I have been doing over the past year or so to raise DES awareness in the UK via our Social Media networks is paying off. As far as I know when Jaymi McCann stumbled upon my "Journal of a DES daughter" she knew little about DES but my story and the information featured in my blog was enough to spark her interest. I can't thank her enough for the extraordinary work she and Sarah Morrison have done to pull this excellent report together. I am grateful for the opportunity they've given me to share my DES story to such a large audience and for the repercussions the report will have for DES daughters and hopefully also DES sons and DES grandchildren in the UK . Now the UK government and the NHS must react, launch an national awareness campaign and ensure DES victims in the UK receive appropriate care and monitoring. Let's keep the pressure on …
Author DES DaughterPosted on 27/01/2012 25/11/2016 Categories Blog, Diethylstilbestrol, Links, MediaTags 2012, DES, Reporter, Sarah Morrison5 Comments on 2012 DES UK Media Coverage
Covering DiEthylStilbestrol worldwide drug disaster
Over the past few days, there has been an unprecedented flurry of media attention on DES related health issues. This come after a long-awaited DES study was published on October 06th in the New England Journal of Medicine (MEJM) which carefully documents elevated risk for women exposed to diethylstilbestrol (DES in short) for a host of medical problems including cancer, infertility, ectopic pregnancies, preterm labour, …. As yet, there has been no coverage from the UK press despite a call on UK journalists to make this information available to the public.
MEDIA COVERAGE IN ENGLISH
Banned pregnancy drug impacts fetal immune system – Jerusalem Post, Oct 12, 2011
DES prescribed to women in the 1940s, 1950s, and 1960s to prevent miscarriages, had serious, untoward effects in daughters of these women, including the development of a rare type of cancer of the uterus. There has been renewed interest in light of a recent report in the New England Journal of Medicine documenting lifelong health complications facing daughters of women given DES.
Diethylstilbestrol in utero affects immune system of the fetus – News Medical, Oct 11, 2011
Reproductive tissues are not the only targets of DES. The immune system is also known to be a target for estrogens. Dr. S. Ansar Ahmed, professor of immunology at Virginia Tech, led a National Institutes of Health study in the 1990s on how exposure to DES in utero affects the immune system later in life using a mouse model.
Suit Claims Drug Leads To Breast Cancer, Victim Speaks Out – 10TV.com, Oct 10, 2011
One woman spoke out on Monday after learning a drug she was given before she was born had life threatening consequences for her as an adult.
Risky pregnancy drug raised daughters' cancer odds – News Channel 9 ABC, Oct 10, 2011
A drug that millions of pregnant women took decades ago to prevent miscarriage and complications has put their daughters at higher risk for breast cancer and other health problems that are showing up now, a new federal study finds.
Pregnancy drug used decades ago raises cancer risk in offspring: study – South Asia Mail
A drug that millions of pregnant women took decades ago to prevent miscarriage and complications has put their daughters at higher risk for breast cancer and other health problems that are showing up now, a new U.S. federal study finds.
Anti-miscarriage drug victim backs campaign – TheMaitlandMecury.com.au, Oct 10, 2011
A woman given the anti-miscarriage drug diethylstilbestrol supports a call for a government-backed education campaign to highlight the dangers of exposure to the medication
Podcast 133: Over 50 years later, DES' adverse effects continue
Oct 8, 2011 – Joe Elia – Audio interview with Dr Hoover, author of the NEJM DES Study
In a follow-up to the DES drug disaster, researchers (including one of the authors of the original reports in the early 1970s) have examined reproductive health in a large cohort of women exposed to DES in utero. Their results were published last week in the New England Journal of Medicine, and they show that the health effects apparently continue beyond the reproductive years
Study adds to furor over pregnancy drug linked to daughter's ailments – The Daily.com, Karen Keller – Oct 7, 2011
The DES breast cancer lawsuit, together with a bombshell New England Journal of Medicine article published yesterday — which suggests that infertility is twice as common and that breast cancer risk is nearly doubled in "DES daughters" — has ushered in a new awareness of the drug after decades when its lingering effects went under the radar.
Women Exposed to Synthetic Estrogen Diethylstilbestrol (DES) in the Womb Face Increased Cancer Risk, Study Finds
Science Daily – Oct 6, 2011 Hayden Donnell
A large study of the daughters of women who had been given DES, the first synthetic form of estrogen, during pregnancy has found that exposure to the drug while in the womb (in utero) is associated with many reproductive problems and an increased risk of certain cancers and pre-cancerous conditions.
Women exposed to diethylstilbestrol in the womb face increased cancer risk – EurekAlert (press release) – Oct 5, 2011
Beginning in 1940, diethylstilbestrol, known as DES, was used clinically to prevent certain complications of pregnancy. In the 1950s, clinical studies showed DES was ineffective for this purpose. In the late 1960s, an unusual occurrence of a rare …
Women Exposed To Hormone In Utero Face Lifelong Health Problems – NPR (blog) – Richard Knox – Oct 5, 2011
Back in the 1940s, '50s and '60s, doctors prescribed a hormone called diethylstilbestrol, or DES, to millions of pregnant women in the unfounded belief it could prevent miscarriages. Smack in the middle of this period, the deformed thalidomide babies …
Synthetic estrogen use leads to health problems
Diethylstilbestrol was prescribed in the mistaken belief it could reduce pregnancy complications, but the daughters of the women who took it are still living with its effects …
Health Risks for Women Exposed to DES in Utero
Doctors Lounge – HealthDay News – Oct 5, 2011
Women who were exposed in utero to diethylstilbestrol have a higher lifetime risk for several adverse health outcomes, according to a study published in the Oct. 6 issue of the New England Journal of Medicine. …
DES Exposure Linked to Lifetime Risk of Adverse Outcomes
Family Practice News Digital Network – Mary Ann Moon – Oct 5, 2011
In-utero exposure to diethylstilbestrol was associated with a high lifetime risk of a broad spectrum of adverse outcomes in a follow-up study of patients now in their 40s, 50s, and 60s, according to a report in the Oct. 6 issue of the New England …
Effects of DES Exposure Follow Women for Decades
MedPage Today – Charles Bankhead – Oct 5, 2011
Explain that the teratogenic effects of diethylstilbestrol have continued to exact a heavy toll throughout the lifetime of women who were exposed to the drug in utero. Point out that DES-exposed women …
Pregnancy Drug is Causing Grown Daughters to Face Risk of Cancer, Infertility – AboutLawsuits.com
The daughters of women given diethylstilbestrol (DES), a drug commonly used decades ago to prevent miscarriages and birth defects, are showing high rates of breast cancer and infertility problems, according to recent research. …
DES daughters (and bummmer, I'm one) have some raised health risks – Los Angeles Times – Oct 5, 2011
Millions of women alive today were exposed to a chemical called DES – diethylstilbestrol – in their mother's uterus. The chemical, an early synthetic estrogen, was administered to some pregnant women before 1971 to help reduce risk of miscarriages and …
Prenatal exposure to synthetic estrogen ups cancer risk in daughters – TruthDive
Washington, Sept 06 (ANI): Daughters of women who took a synthetic estrogen called diethylstilbestrol (DES) while pregnant decades ago are now facing a greater chance of being infertile and developing cancer, according to a large study by the National …
Pregnancy drug found to cause fertility woes, cancers
The study in Thursday's New England Journal of Medicine examines the daughters of females exposed in the womb to diethylstilbestrol (DES), which was prescribed in the mistaken belief it could reduce certain complications of pregnancy. …
Anti-miscarriage drug DES causes multi-generational health problems – Macleans.ca
by macleans.ca on Thursday, October 6, 2011 12:56pm – 0 Comments DES (or diethylstilbestrol), an anti-miscarriage drug widely used between 1940 and 1970, has been linked to health problems—including breast cancer, infertility, difficult pregnancies and …
"DES" increases women infertility and cancers
Empowered News
DES or diethylstilbestrol have been prescribed to pregnant women for the belief that it will reduce complications during pregnancy. The National Cancer Institute researchers and scientists have been following about 6500 women including those exposed to …
Health Woes Still Strike Women Exposed to Banned Pregnancy Drug – U.S. News & World Report – Oct 5, 2011
Women whose mothers were given the drug diethylstilbestrol (DES) during pregnancy are at increased risk for fertility problems and cancer as they age, new research shows. This study from the US National Cancer …
DES cancer link sparks campaign call
Sydney Morning Herald – Oct 5, 2011
A study published by the New England Journal of Medicine on Thursday found daughters of women who took diethylstilbestrol (DES) while pregnant face a greater chance of being infertile and developing a rare vaginal cancer. …
DES linked to cancer, infertility
A study appearing in Thursday's New England Journal of Medicine examines women exposed in the womb to diethylstilbestrol (DES), which was prescribed in the mistaken belief it could reduce certain complications of pregnancy. Researchers at the National …
In Utero DES Exposure Hurt Daughters' Health
CalorieLab Calorie Counter News – Oct 5, 2011
A comprehensive study looking at the drug diethylstilbestrol (DES) that was widely used by pregnant women in Europe and the United States to prevent problems in pregnancy such as miscarriage and premature birth from the 1940s until the 1960s suggests …
Fake Hormone For Pregnant Women Causes Real Cancer In Their Daughters – Jezebel
The Associated Press reports that the drug, an artificial form of estrogen called DES (diethylstilbestrol), was often prescribed to pregnant women in pill or cream form between 1940 and 1960. When it was discovered that the teenage daughters of women …
DES Daughters: Banned Pregnancy Drug Linked to Infertility, Prematurity and Cancer – TIME – Bonnie Rochman
That drug was DES, or diethylstilbestrol, which was widely prescribed in the US beginning in 1940 to help stave off miscarriage — until 1971, when the US Food and Drug Administration decided that the drug doesn't work and that it causes cancer. …
Risky pregnancy drug raised daughters' cancer odds
Coshocton Tribune
Diethylstilbestrol, or DES, widely was used in the United States, Europe and elsewhere from the 1940s through the 1960s to prevent miscarriage, premature birth, bleeding and other problems. Many companies made it as pills and creams. …
Moms who took miscarriage drug DES have daughters with higher risk for breast … – New York Daily News
DES, or diethylstilbestrol, was widely used in the United States, Europe and elsewhere from the 1940s through the 1960s to prevent miscarriage, premature birth, bleeding and other problems. Many companies made and sold it as pills, creams and other …
Prenatal exposure to synthetic estrogen ups cancer risk in daughters – BioScholar News
Daughters of women who took a synthetic estrogen called diethylstilbestrol (DES) while pregnant decades ago are now facing a greater chance of being infertile and developing cancer, according to a large study by the National Cancer Institute in the …
Pregnancy drug raised daughters'cancer odds
Post-Tribune – Marilynn Marchione – Oct 5, 2011
Risks for other health problems vary. DES, or diethylstilbestrol, was widely used in the United States, Europe and elsewhere from the 1940s through the 1960s to prevent miscarriage, premature birth, bleeding and other problems.
Pregnancy drug raised daughters' cancer odds
Salt Lake Tribune – Marilynn Marchione – Oct 5, 2011
AP A drug that millions of pregnant women took decades ago to prevent miscarriage and complications has put their daughters at higher risk for breast cancer and other health problems that are showing up now, a new federal study …
Pregnancy Drug proving a risk for children – WREG
Millions of women in the 1940s, 50s, and 60s who wanted to make sure they had safe pregnancies, took a drug called DES. The women likely didn`t know it then, but that drug came with side effects that are surfacing 50 plus years later in their children. …
Today's Top Medical Stories for October 6, 2011
OzarksFirst.com – Oct 6, 2011
Millions of women exposed to the first synthetic form of estrogen are at risk of cancer . A National Institutes of Health study followed daughters of pregnant women given synthetic estrogen called DES from the 1940's to the 1970s. …
Drugs women took years ago may affect daughters
A drug millions of pregnant women took decades ago may increase health risks among their daughters. An estimated four million Americans were exposed to DES, a synthetic estrogen prescribed to prevent miscarriages and pregnancy complications, …
KTUU – Oct 5, 2011
A new federal study finds that a drug that millions of pregnant women took decades ago to prevent miscarriage and complications has put their daughters at higher risk for breast cancer. Cancer and other health problems are showing …
Drug To Prevent Miscarriage Increases Odds for Breast Cancer
Heal Blog (blog) – Oct 5, 2011
by Art Writ, October 6th, 2011 Decades ago, women have taken a certain drug that lessens the risk of miscarriage. However, just recently, researchers have found out that the complications and side effects of this drug has placed their daughters at …
MEDIA COVERAGE IN FRENCH
L'exposition fœtale au Distilbène accroît les risques de certains cancers – Le Monde – 6 oct. 2011
Les femmes exposées dans le ventre de leur mère au Distilbène, premier œstrogène de synthèse utilisé dès 1940, souffrent de nombreux problèmes de reproduction et sont soumises à un net accroissement du risque de certains cancers, selon une vaste étude …
Distilbène : de nouveaux risques de cancers identifiés
Magic Maman – 6 oct. 2011
Une étude menée par les chercheurs de l'Institut National du Cancer américain publiée aujourd'hui dans le New England Journal of Medecine révèle de nouveaux effets négatifs liés à l'exposition intra-utérine au distilbène. En cause : des risques accrus …
Les femmes exposées au Distilbène au stade foetal ont plus de problèmes de santé – Maxisciences – 6 oct. 2011
Une étude menée par des chercheurs de l'Institut national américain du cancer (NCI) montre que des femmes exposées au stade fœtal au Distilbène, un œstrogène de synthèse, souffrent aujourd'hui de problèmes de reproduction et sont davantage sujettes à …
Filles du Distilbène : un risque accru de cancers
Terrafemina – 6 oct. 2011
Les résultats d'une vaste étude publiée aujourd'hui dans le New England of Medicine révèlent que les femmes exposées au Distilbène dans le ventre de leur mère sont soumises à un risque accru de cancer. Entre 1948 et 1976, 200 000 femmes ont été …
Author DES DaughterPosted on 07/10/2011 18/05/2016 Categories Blog, Diethylstilbestrol, Links, Media, Women's HealthTags 2011, DES, NEJM, New England Journal of Medicine, research, study17 Comments on 2011 DES Study Media Coverage


Just 2 hours from Ebbsfleet International, Europe's cultural capital has never been more accessible.
Whether you're travelling for business or pleasure, Ebbsfleet International is the perfect place to begin your journey. See our trains page for more information on getting to Paris.
The Eurostar runs direct trains from Ebbsfleet International to Paris six times a day Mon-Fri, four times a day on a Saturday and three times a day on a Sunday.


Discussion in 'Group C Honey Jar Series Closed' started by John vd Geest, Apr 14, 2018.
The link above is the final skin pack for all drivers. It includes SRO deafault skins and custom made skins by drivers.
Please download this skin pack and install it.
Use the "Steam" folder to install and NOT the SRO Cars folder (that one is incomplete).
Installing this SRO skin pack is mandatory. We must all have the SRO logo's.
Select the car you want to drive below.
The car you select for your first race will be your car for the entire season, so choose wisely.
If there are any Mercedes-Benz C9 left open, we can make that a Mazda or Porsche.
Yeah man, that beast makes some noise. I was really unsure between the Porsche and the Mazda. It's a great car on the shorter tracks and possibly a race winner there and the handeling is amazing, so good choice.
Is it possible to get fixed skins/startnumbers? It adds to the immersion by better recognition of opponents.
Yes, they are working on that.
Not sure if this will be allowed. I was going to work on a quick skin for the 787B for my entry. You would all need to install the files to see it on your screens, otherwise the car will appear white. If not that's fine. I'll stick to a game livery, let me know either way.
I do not need a homemade skin, just the stock ones if they can be fixed for the season. The #77 Motul for me please.
For what car is that?
@John vd Geest . Mazda 787b #77 Motul (stock assetto corsa skin).
Don't forget to post the skin with witch you want to drive. Posting a picture also helps. See my example.
Mazda please. Martini colours if that's ok.
Do I still need to purchase the porsche pack?.
Which layout of riverside our we using in round one. Many thanks Sean.
Hi Sean, please post your Mazda skin here like I did (03_racing_7). The skin you select has a number.
Yes, if you don't have the Porsche Pack 2, you don't match up with the server (It can't display the Porsche cars for you and you can't enter the server because you're missing that car).


Our College Park TOEFL instructor has many years of experience teaching English and ESL to students ranging in age from elementary school to college age. She received her Master's degree in Speech and Language Pathology from Towson State University.
I had a very good learning experience during all my TOEFL online classes with Kara. She could take my English and knowledge to a higher level that is helping me with my TOEFL objectives. She also performed a very important role of being mentor and advisor during all the process. The TOEFL preparation process is long and requires dedication. By using updated topics, hints and learning method she could extract the best from my dedication. I strongly recommend her to any student that is looking for a very pleasant and fruitful class. She was always available, even at very early time slot in the morning, to support me achieving the goals. I still have some TOEFL tests to finish by I'm certain that she was the big responsible to all good results I'm having at my tests. Also I would like to thank you all Manhattan team that also showed a very fast response to all my needs.


text:
Match starts in 1 hr 58 mins
Momentum One Day Cup 2018/19
1st Match (D/N), Paarl, February 08, 2019, Momentum One Day Cup
Cape Cobras
Warriors won by 3 wickets (with 1 ball remaining)
Series Home
2nd Match, Pietermaritzburg, February 09, 2019, Momentum One Day Cup
Dolphins won by 19 runs
Sun, 10 Feb
3rd Match, Centurion, February 10, 2019, Momentum One Day Cup
Titans won by 9 wickets (with 68 balls remaining)
Wed, 13 Feb
4th Match (D/N), Johannesburg, February 13, 2019, Momentum One Day Cup
(16.2/50 ov) 76/3
6th Match, Centurion, February 17, 2019, Momentum One Day Cup
7th Match (D/N), Bloemfontein, February 19, 2019, Momentum One Day Cup
Cape Cobras won by 3 wickets (with 3 balls remaining)
8th Match (D/N), Paarl, February 22, 2019, Momentum One Day Cup
(49/50 ov, T:277) 254
9th Match (D/N), Kimberley, February 22, 2019, Momentum One Day Cup
(45.1/47 ov) 195
Warriors won by 14 runs (D/L method)
10th Match, Oudtshoorn, February 24, 2019, Momentum One Day Cup
Cape Cobras won by 21 runs
11th Match (D/N), Durban, February 26, 2019, Momentum One Day Cup
(28/31 ov, T:152) 152/2
Warriors won by 8 wickets (with 18 balls remaining) (D/L method)
12th Match (D/N), Potchefstroom, February 27, 2019, Momentum One Day Cup
LIONS won by 8 wickets (with 18 balls remaining)
Fri, 01 Mar
13th Match (D/N), Cape Town, March 01, 2019, Momentum One Day Cup
Titans won by 83 runs
14th Match (D/N), East London, March 01, 2019, Momentum One Day Cup
Warriors won by 7 runs (D/L method)
Sat, 02 Mar
15th Match (D/N), Durban, March 02, 2019, Momentum One Day Cup
Dolphins won by 22 runs (D/L method)
Sun, 03 Mar
16th Match, Gqeberha, March 03, 2019, Momentum One Day Cup
Thu, 07 Mar
17th Match (D/N), Johannesburg, March 07, 2019, Momentum One Day Cup
Cape Cobras won by 3 runs
18th Match (D/N), Benoni, March 08, 2019, Momentum One Day Cup
(21/21 ov) 132/4
Titans won by 2 wickets (with 4 balls remaining) (D/L method)
19th Match, Pietermaritzburg, March 09, 2019, Momentum One Day Cup
Cape Cobras won by 8 wickets (with 12 balls remaining)
20th Match (D/N), Bloemfontein, March 09, 2019, Momentum One Day Cup
Wed, 13 Mar
21st Match (D/N), Centurion, March 13, 2019, Momentum One Day Cup
Titans won by 10 wickets (with 167 balls remaining)
23rd Match (D/N), Durban, March 15, 2019, Momentum One Day Cup
22nd Match (D/N), East London, March 15, 2019, Momentum One Day Cup
Knights won by 5 wickets (with 123 balls remaining)
24th Match, Kimberley, March 17, 2019, Momentum One Day Cup
Knights won by 58 runs
25th Match (D/N), Gqeberha, March 20, 2019, Momentum One Day Cup
Dolphins won by 9 wickets (with 85 balls remaining)
26th Match, Cape Town, March 21, 2019, Momentum One Day Cup
27th Match, Benoni, March 21, 2019, Momentum One Day Cup
LIONS won by 7 runs
Warriors won by 9 wickets (with 36 balls remaining)
Knights won by 5 wickets (with 6 balls remaining) (D/L method)
30th Match (D/N), Potchefstroom, March 23, 2019, Momentum One Day Cup
(9.2/48 ov, T:323) 39/1
1st Semi final (D/N), Centurion, March 27, 2019, Momentum One Day Cup
2nd Semi final (D/N), Durban, March 28, 2019, Momentum One Day Cup
Dolphins won by 7 wickets (with 185 balls remaining)
Final, Centurion, March 31, 2019, Momentum One Day Cup
Titans won by 135 runs
On This Day: Happy birthday, Asad Shafiq
Quote Unquote: who's saying what?
Summers with Greenidge and Marshall
The latest cricket photos
Suryakumar Yadav: 'Wanted to do things my way, and it worked for me'
Who does it best?
Photo feature: all about the team bus
Records index: most runs, most wickets, and a lot more
How Rovman Powell grabbed his cricket ticket out of poverty
Rankings: Who's leading in every format
Harshal Patel: 'Nothing wrong in bowling 24 slower balls in a T20 spell'

redpajama_set_name: RedPajamaCommonCrawl


Definition of Solar System bodies: Neptune Until the discovery of Pluto in 1930, Neptune was supposed to be the outermost member of the solar system. It was discovered September 23, 1846 by Galle in Berlin, in the region suggested by Leverrier of Paris; but later was identified as the "star" observed in 1795 by Lalande of Paris. Agrippa dedicated a temple to Neptune in honor of the naval victory of Actium. To the Greeks, known as Poseidon. It is a greenish disc of the magnitude of 7.7, and is distant from Earth by 30 astrom. units. Its revolutionary period is 164y.
It has one known satellite, Triton, about the size of our Moon, and 220,000 miles distant from the planet. It has a magnitude of 13. Its period is 5d, 21h, its orbit inclined to the Neptune orbit by an angle of 40�; its motion retrograde, with a recession period of 580y, or 140� direct. Inclination of Triton's orbit to Neptune's equator is 20�.
Neptune was in Virgo from 1435 to 1449; from 1600 to 1614; from 1761 to 1778; and most recently from 1921 to 1942. It was in Libra from 1450 to 1465; from 1615 to 1635; from 1779 to 1793; and 1943 to 1957.